Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
Stock Information for Cardiol Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.